Process Engineering STREAM

1. Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit 3/13/2026

   See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.

2. Go Beyond Custom Media Screening And Prototyping 3/13/2026

   Learn about manufacturing solutions that streamline cell culture media scale-up with global production capabilities, equivalency strategies, and quality assurance for reliable supply.

3. Accelerating Novel Cell Therapies To Market 3/20/2024

   Learn about two matrices that, when combined, provide an optimal solution for the process development and manufacturing of novel induced pluripotent stem cell therapies.

4. Key Functions Of The ÄKTA Oligosynt Synthesizer 2/16/2023

   Discover a compact, fully automated oligonucleotide synthesizer for robust, scalable process development. Learn how it can help establish a robust and reproducible oligo synthesis process.

5. Meet The Experts: Part 2 - Raman Spectroscopy 5/1/2023

   Watch part 2 of this 4-part interview series to explore Raman spectroscopy, one of the main PAT tools for monitoring bioprocess CQAs and CPPs, with expert Fabien Caron.

6. A Closed And Automated Solution For Cell Therapy Manufacturing 3/1/2024

   Streamline your cell therapy manufacturing process and workflow by automating and closing your cell isolation, cell harvest, and formulation with a system designed to offer you versatility.

7. Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities 7/8/2022

   View this video and discover our global vaccine capabilities from process development to full-scale GMP-manufacturing and in all modalities.

8. Nanoassemblr Blaze mRNA Vaccine Demo 4/13/2022

   NxGen Technology delivers a scalable means to perform the critical particle formation step in a nanomedicine development process.

9. Small-Scale Oligonucleotide Synthesizer That Supports Scale Up 2/16/2023

   Learn about a small oligonucleotide synthesizer with big impact that features a user-friendly interface, compact footprint, and more. This small scale system is user friendly and supports scale up.

10. Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D. 10/20/2025

    In this episode of "Better Biopharma," host Tyler Menichiello is joined by MindImmune's president and CEO, Stevin Zorn, Ph.D. They discuss the development of the company's lead candidate, MITI-101, a monoclonal antibody designed to prevent peripheral immune cells from entering the brain and driving neuroinflammation linked to Alzheimer's disease.